Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.14.5 extracted from

  • Lee, H.K.; Kim, M.K.; Kim, H.D.; Kim, H.J.; Kim, J.W.; Lee, J.O.; Kim, C.W.; Kim, E.E.
    Unique binding mode of evogliptin with human dipeptidyl peptidase IV (2017), Biochem. Biophys. Res. Commun., 494, 452-459 .
    View publication on PubMed

Crystallization (Commentary)

Crystallization (Comment) Organism
in complex with inhibitor (3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one. The binding of the trifluorophenyl moiety in the S1 pocket and the piperazine-2-one moiety have hydrophobic interactions with Phe357 in the S2 extensive subsite, and the multiple hydrogen bonds made by the (R)-beta-amine group in the S2 pocket and the contacts made by the (R)-tert-butyl group with Arg125 contribute to the high potency of the inhibitor Homo sapiens

Inhibitors

Inhibitors Comment Organism Structure
(3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one i.e. evogliptin Homo sapiens

Organism

Organism UniProt Comment Textmining
Homo sapiens P27487
-
-